Testosterone-estradiol-binding globulin in patients with Turner's syndrome: effects of estrogens and acute growth hormone administration.
The TeBG activity of plasma from patients with Turner's syndrome was measured quantitatively using polyacrylamide gel electrophoresis. Human growth hormone administration did not significantly change the plasma TeBG levels. However, oral replacement therapy with estrogens elevated plasma TeBG within 3 days; after 9 days these levels reached a maximum of three- to four-fold greater than that observed at a time prior to therapy.
D000293:Adolescent; D000365:Age Determination by Skeleton; D002648:Child; D004958:Estradiol / Q000097:blood*; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use*; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D011485:Protein Binding; D012712:Serum Globulins / Q000378:metabolism*; D013739:Testosterone / Q000097:blood*; D014424:Turner Syndrome / Q000097:blood* / Q000188:drug therapy
D004966:Estrogens, Conjugated (USP); D012712:Serum Globulins; D013739:Testosterone; D004997:Ethinyl Estradiol; D004958:Estradiol; D013006:Growth Hormone